Study shows surgery, radiation extend survival of patients with limited metastatic lung cancer

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

A study led by researchers from MD Anderson Cancer Center shows that radiation or surgical removal of metastatic tumors provides a major survival advantage for lung cancer patients with minimal stage IV disease who have not progressed after frontline chemotherapy.

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe
Table of Contents

YOU MAY BE INTERESTED IN

For decades, we have faced a central challenge in colorectal cancer screening. One in three eligible Americans—over 50 million people—remain unscreened despite established methods like colonoscopy or stool-based tests existing for decades. This gap persists even though early detection saves lives, and even as colorectal cancer is now the number one cancer killer for Americans under 50.

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login